Michael Greeley

Cohere Health’s Series C: Case Study…

Kyle Harrison

Automating Clinical Trials (with Josh Pacini @ Valinor)

Better Tomorrow Ventures

1Q25 Newsletter

A Wealth of Common Sense | Ben Carlson

Animal Spirits: Winners & Losers From the Stock Market Rally

Kyle Poyar's Growth Unhinged | Kyle Poyar

You need a better testing strategy

Digital Native | Rex Woodbury

Synthetic Populations

Saastr

Dear SaaStr: What’s The Best Ways to Part With A Leader?

Akshay Mehra

The Invisible Game

Feld Thoughts | Brad Feld

Random Day on 5/28 at The Composition Shop

My Climate Journey | Jason Jacobs

The Tariff Roller Coaster: How Founders Are Navigating Trade Volatility

Greycroft.com

Unlocking The Wisdom Of The Crowds: Our Investment in Sequen

A Wealth of Common Sense | Ben Carlson

84-Month Auto Loans?!

Insight Partners

Data that delivers: Azara Healthcare turns complexity into clarity for America’s safety net

Dash Media

🎙️ Ep. 45 · ASU President Dr. Michael Crow | Ed on the Edge

First Round Review

Thinking About Taking the Founder Leap? Here’s How to Prep for the Emotional Gauntlet

Insight Partners

PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients

Saastr

It May Be Easier to Sell a Second Product to New Customers, Not Existing Ones

Scale Venture Partners

Announcing our investment in ClearVector

USV

You Can Just Program Biology

Matt Brown

Why VC and software have PE envy

Lenny's Newsletter

State of the product job market in 2025

Not Boring | Packy McCormick

Everything is Technology

Dawn Capital

Part II: Why AI Agents & Copilots Will Unlock Trillion‑Dollar Value

Pirate Wires | Mike Solana

To Revitalize American Shipbuilding, We Must DOGE the Jones Act

Saastr

Dear SaaStr: Our Biggest Potential Customers Are All Asking for Custom Features. When Do We Say Yes?